Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
G

Global Health Ltd
BSE:543654

Watchlist Manager
Global Health Ltd
BSE:543654
Watchlist
Price: 1 320.7 INR -0.53% Market Closed
Market Cap: ₹354.7B
Write Note Create Alert Ask AI

Wall St Price Targets

MEDANTA Price Targets Summary
Global Health Ltd

Wall Street analysts forecast MEDANTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDANTA is 1 429.09 INR with a low forecast of 1 217.7 INR and a high forecast of 1 642.56 INR.

MEDANTA Lowest Forecast
1 217.7 INR
-8% Downside
MEDANTA Average Forecast
1 429.09 INR
8% Upside
MEDANTA Highest Forecast
1 642.56 INR
24% Upside
Lowest Forecast
Price Target
1 217.7 INR
8% Downside
Average Forecast
Price Target
1 429.09 INR
8% Upside
Highest Forecast
Price Target
1 642.56 INR
24% Upside
Global Health Ltd Competitors:
Price Targets
TEX
Terex Corp
18% Upside
CEG
Constellation Energy Corp
44% Upside
TEX
Terex Corp
18% Upside
CEG
Constellation Energy Corp
44% Upside

Revenue
Forecast

26% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
26% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 4 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 4 years is 17%.

What are analyst estimates?

Gross Profit
Forecast

27% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
27% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 4 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 4 years is 18%.

What are analyst estimates?

Operating Income
Forecast

76% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
76% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 4 years, the compound annual growth rate for Operating Income has been 76%. The projected CAGR for the next 4 years is 16%.

What are analyst estimates?

Pre-Tax Income
Forecast

111% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
111% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 111%. The projected CAGR for the next 3 years is 21%.

What are analyst estimates?

Net Income
Forecast

102% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
102% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 4 years, the compound annual growth rate for Net Income has been 102%. The projected CAGR for the next 4 years is 19%.

What are analyst estimates?

Continue MEDANTA Research

Summary
MEDANTA intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDANTA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDANTA stock valuation using valuation multiples.
Wall St Estimates
MEDANTA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDANTA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Global Health Ltd listings:
NSE • INR
MEDANTA
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MEDANTA's stock price target?
Price Target
1 429.09 INR

According to Wall Street analysts, the average 1-year price target for MEDANTA is 1 429.09 INR with a low forecast of 1 217.7 INR and a high forecast of 1 642.56 INR.

What is the Revenue forecast for Global Health Ltd?
Projected CAGR
17%

Over the last 4 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 4 years is 17%.

What is the Gross Profit forecast for Global Health Ltd?
Projected CAGR
18%

Over the last 4 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 4 years is 18%.

What is the Operating Income forecast for Global Health Ltd?
Projected CAGR
16%

Over the last 4 years, the compound annual growth rate for Operating Income has been 76%. The projected CAGR for the next 4 years is 16%.

What is the Pre-Tax Income forecast for Global Health Ltd?
Projected CAGR
21%

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 111%. The projected CAGR for the next 3 years is 21%.

What is the Net Income forecast for Global Health Ltd?
Projected CAGR
19%

Over the last 4 years, the compound annual growth rate for Net Income has been 102%. The projected CAGR for the next 4 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join 348,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett